Organigram Global (OGI) Research & Development (2018 - 2021)

Organigram Global (OGI) has reported Research & Development for 4 consecutive years, with $10.9 million the latest figure, recorded in Q2 2021.

• On a quarterly basis, Research & Development rose 153.99% year-over-year to $10.9 million in Q2 2021; TTM through May 2021 was $22.7 million, a 30.64% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, changed N/A from the prior year.
• Research & Development was $10.9 million for Q2 2021 at Organigram Global, up from $6.8 million in the prior quarter.
• Over five years, Research & Development peaked at $10.9 million in Q2 2021 and troughed at $646000.0 in Q4 2020.
• A 4-year average of $4.4 million and a median of $4.3 million in 2020 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 197.65% in 2019 and decreased 3.2% in 2020, its largest moves.
• Over 4 years, Research & Development stood at $2.1 million in 2018, then jumped by 112.69% to $4.4 million in 2019, then tumbled by 85.45% to $646000.0 in 2020, then soared by 1590.25% to $10.9 million in 2021.
• The last three Research & Development figures came in at $10.9 million (Q2 2021), $6.8 million (Q1 2021), and $646000.0 (Q4 2020), per Business Quant data.